Alliance A071701 (Brain Metastases)
What is the Purpose of this Study?
If you choose to join this study, you will:
- Have blood draws
- Have EKG's (a way to measure your heart activity)
- Take 1 of the 3 study drugs that is assigned to your specific cancer
-- The 3 types of medication are Abemaciclib, GDC-0084, and Entrectinib
- Keep a pill diary (to help track when you take your pills)
- Have blood draws
- Have EKG's (a way to measure your heart activity)
- Take 1 of the 3 study drugs that is assigned to your specific cancer
-- The 3 types of medication are Abemaciclib, GDC-0084, and Entrectinib
- Keep a pill diary (to help track when you take your pills)
What is the Condition Being Studied?
Brain Metastases
Who Can Participate in this Study?
Adults diagnosed with brain metastases
Age Group
Adults
Participating Institutions
What is Involved?
We are doing this study to learn more about the side effects of the study drug and to determine if it will help shrink the cancer by at least 30%.
Study Details
Full Title
Alliance A071701: Genomically-Guided Treatment Trial in Brain Metastases
Principal Investigator
Protocol Number
IRB:
PRO00104080
NCT:
NCT03994796
ClinicalTrials.gov
View on ClinicalTrials.gov